Aegate Revenue
Technology, Information and Internet • 
Royston, England, United Kingdom • 11-20 Employees
Aegate revenue & valuation
| Annual revenue | $10,000,000 |
| Revenue per employee | $625,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Technology, Information and Internet industry and current estimated revenues | $32,000,000 |
| Total funding | No funding |
Key Contact at Aegate
Erik Merny
Director Belgium
Company overview
| Headquarters | H9 The Courtyard, Melbourn Science Park, Melbourn, Herts SG8 6HB, GB |
| Phone number | +442078211925 |
| Website | |
| SIC | 737 |
| Keywords | Anti-Counterfeiting, Falsified Medicines Directive, Patient Safety, Product Authentication |
| Founded | 2004 |
| Employees | 11-20 |
| Socials |
Aegate Email Formats
Aegate uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 42.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 42.1% |
{first name}@company.com | john@company.com | 25.3% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 14.8% |
{first name}{last name}@company.com | johndoe@company.com | 10.2% |
{last name}@company.com | doe@company.com | 7.6% |
About Aegate
Aegate is the world leader in the digital authentication of medicines. Patient safety is the reason for our existence and that commitment drives our innovation and service delivery. Our mission is to protect patients from falsified, counterfeit, recalled or expired medicines. Our secure real-time service verifies the authenticity of medicines. Operating seamlessly from manufacturer database through to point of dispense in pharmacy, our service fully meets the requirements of the EU Falsified Medicines Directive. Our Experience What makes the Aegate authentication service unique is its proven ability to work in the live dispensing environment. Aegate has many practical operations (they are not trials or tests) across Europe that have demonstrated clear benefits: • Long term performance measurement of speed of response, accuracy and security. Proving the robust nature of the service. • We understand that when it comes to implementing a successful authentication service, the devil is in the detail. • Our service has enabled pharmacists to understand more about this important new patient safety legislation and to prepare their own systems, work flows and staff for the changes ahead Our Technology Aegate has invested over ten years into building our technology and the skills and expertise of the team who continue to develop system performance. Our authentication service is built on three key pillars of: • Exceptional speed of response • Efficient service scalability • Excellent system security These pillars enable complete compliance with the requirements of the Falsified Medicines Directive for all stakeholders. They are unmatched by rival systems. Our unique technology is the only authentication service being used by pharmacies across Europe every day and therefore has proven performance and reliability.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Funding Data
Aegate has never raised funding before.
Aegate Tech Stack
Discover the technologies and tools that power Aegate's digital infrastructure, from frameworks to analytics platforms.
Reverse proxies
United States
GermanyFrequently asked questions
4.8
40,000 users
